Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure.

OBJECTIVES This study was conducted to evaluate whether brain (B-type) natriuretic peptide (BNP) changes during sleep are associated with the frequency and severity of apneic/hypopneic episodes, intermittent arousals, and hypoxia. BACKGROUND Sleep apnea is strongly associated with heart failure (HF) and could conceivably worsen HF through increased sympathetic activity, hemodynamic stress, hypoxemia, and oxidative stress. If apneic activity does cause acute stress in HF, it should increase BNP. METHODS Sixty-four HF patients with New York Heart Association functional class II and III HF and ejection fraction <40% underwent a baseline sleep study. Five patients with no sleep apnea and 12 with severe sleep apnea underwent repeat sleep studies, during which blood was collected every 20 min for the measurement of BNP. Patients with severe sleep apnea also underwent a third sleep study with frequent BNP measurements while they were administered oxygen. This provided 643 observations with which to relate apnea to BNP. The association of log BNP with each of 6 markers of apnea severity was evaluated with repeated measures regression models. RESULTS There was no relationship between BNP and the number of apneic/hypopneic episodes or the number of arousals. However, the burden of hypoxemia (the time spent with oxygen saturation <90%) significantly predicted BNP concentrations; each 10% increase in duration of hypoxemia increased BNP by 9.6% (95% confidence interval: 1.5% to 17.7%, p = 0.02). CONCLUSIONS Hypoxemia appears to be an important factor that underlies the impact of sleep abnormalities on hemodynamic stress in patients with HF. Prevention of hypoxia might be especially important for these patients.

[1]  P. L. Smith,et al.  The effect of chronic nocturnal oxygen administration upon sleep apnea. , 2015, The American review of respiratory disease.

[2]  E. Phillipson,et al.  Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. , 1997, The Journal of clinical investigation.

[3]  A. Maisel,et al.  B-type natriuretic peptide in the diagnosis and management of congestive heart failure. , 2001, Cardiology clinics.

[4]  B. Lüderitz,et al.  NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure , 2006, Clinical Research in Cardiology.

[5]  P. L. Smith,et al.  Airway obstruction during sleep increases blood pressure without arousal. , 1996, Journal of applied physiology.

[6]  W K Lam,et al.  Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. , 2000, American journal of respiratory and critical care medicine.

[7]  P. L. Smith,et al.  Reflex stimulation of renal sympathetic nerve activity and blood pressure in response to apnea. , 1996, American journal of respiratory and critical care medicine.

[8]  I. Chaudry,et al.  Hypoxemia in the absence of blood loss or significant hypotension causes inflammatory cytokine release. , 1995, The American journal of physiology.

[9]  F. Boomsma,et al.  NT-pro-BNP during hypoglycemia and hypoxemia in normal subjects: impact of renin-angiotensin system activity. , 2008, Journal of applied physiology.

[10]  J. Krieger,et al.  Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure. , 1989, Clinical science.

[11]  A. Maisel,et al.  Natriuretic peptides. , 2007, Journal of the American College of Cardiology.

[12]  K. Gourgoulianis,et al.  Overnight change in brain natriuretic peptide levels in children with sleep-disordered breathing. , 2006, Chest.

[13]  P. L. Smith,et al.  Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea. , 2000, Journal of applied physiology.

[14]  T. Douglas Bradley,et al.  Sleep Apnea and Heart Failure: Part I: Obstructive Sleep Apnea , 2003, Circulation.

[15]  A. Ngan,et al.  A universal relation for the stress dependence of activation energy for slip in body-centered cubic crystals , 1999 .

[16]  A. Maisel,et al.  State-of-the-Art PaperNatriuretic Peptides , 2007 .

[17]  R Colombo,et al.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. , 1999, Circulation.

[18]  S. Houser,et al.  Anoxic contractile failure in rat heart myocytes is caused by failure of intracellular calcium release due to alteration of the action potential. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J S Floras,et al.  Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. , 1999, American journal of respiratory and critical care medicine.

[20]  Lanfranchi Pa,et al.  Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure , 2009 .

[21]  N. Cherniack,et al.  Cheyne-Stokes breathing. An instability in physiologic control. , 1973, The New England journal of medicine.

[22]  J. Ringler,et al.  Systemic blood pressure elevation after airway occlusion during NREM sleep. , 1994, American journal of respiratory and critical care medicine.

[23]  Frank J Giordano,et al.  Oxygen, oxidative stress, hypoxia, and heart failure. , 2005, The Journal of clinical investigation.

[24]  Ling Chen,et al.  Mechanisms of acute cardiovascular response to periodic apneas in sedated pigs. , 1999, Journal of applied physiology.

[25]  D. Rapoport,et al.  Non-Invasive detection of respiratory effort-related arousals (REras) by a nasal cannula/pressure transducer system. , 2000, Sleep.

[26]  W. Seeger,et al.  Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. , 2000, American journal of respiratory and critical care medicine.

[27]  M. Weisfeldt,et al.  Mechanism of Early Contractile Failure During Hypox in Intact Ferret Heart: Evidence for Modulation of Maximal Ca2+‐Activated Force by Inorganic Phosphate , 1986, Circulation research.

[28]  A. Logan,et al.  Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. , 2000, Circulation.

[29]  P. L. Smith,et al.  A shift from central and mixed sleep apnea to obstructive sleep apnea resulting from low-flow oxygen. , 1985, The American review of respiratory disease.

[30]  V. Somers,et al.  Plasma brain natriuretic peptide in obstructive sleep apnea. , 2004, The American journal of cardiology.

[31]  V. Somers,et al.  Central Sleep Apnea in Left Ventricular Dysfunction: Prevalence and Implications for Arrhythmic Risk , 2003, Circulation.

[32]  K. Chin,et al.  The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure , 1998, Journal of sleep research.

[33]  P. McLaughlin,et al.  Cardiac output response to continuous positive airway pressure in congestive heart failure. , 1992, The American review of respiratory disease.

[34]  V. Somers,et al.  Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. , 2000, American journal of physiology. Heart and circulatory physiology.

[35]  N. Cherniack,et al.  Sleep apnea considered as a control system instability. , 1982, Respiration physiology.